Company News in the Life Science Industry

»

Reset 

Extendicare Announces Timing of 2020 Second Quarter Results and Conference Call

Read more ››
By: GlobenewsWire - 10 Jul 2020

Todos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USA

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  Todos Medical Ltd.

Inventiva announces trading resumption of its ordinary shares on Euronext Paris

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  Inventiva Pharma

Generex Biotechnology Announces Corporate Update and Investor Conference Call: NuGenerex Immuno-Oncology Today Friday July 10, 2020 at 4:15 PM

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  Generex Biotechnology Corp. | Genovior Biotech Corporation

Tauriga Sciences, Inc. Chief Executive Officer Seth M. Shaw Completes Insider Purchase -- 700,000 Shares @ $0.05 per Share

Read more ››
By: GlobenewsWire - 10 Jul 2020

DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  DBV Technologies S.A.

Beroni Group to Supply COVID-19 Antibody Test Kit to Japan

Read more ››
By: GlobenewsWire - 10 Jul 2020

MedMira’s July Update as per the IIROC Request

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  MedMira Inc.

The Dermatology Office in Dallas Welcomes Back Patients

Read more ››
By: GlobenewsWire - 10 Jul 2020

The Jacobs Center Embraces Virtual Consultations

Read more ››
By: GlobenewsWire - 10 Jul 2020

Tauriga Sciences, Inc. Completes Payment for the Entirety of its Initial Production Run of its Pear Bellini Flavor Immune Booster Tauri-Gum Version

Read more ››
By: GlobenewsWire - 10 Jul 2020

Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2020

Read more ››
By: GlobenewsWire - 10 Jul 2020

National Lipid Association Releases Official Scientific Statement on Genetic Testing in Dyslipidemia

Read more ››
By: GlobenewsWire - 10 Jul 2020

BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  BioSig Technologies, Inc.

Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money Report

Read more ››
By: GlobenewsWire - 10 Jul 2020
Related companies:  Tiziana Life Sciences plc

Rossari First IPO to do Virtual Roadshow

Companies adopt Virtual Roadshows for Capital Raise

Read more ››
By: PR Newswire Association LLC. - 10 Jul 2020

CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline Results of Phase 2 Trial

TAIPEI, July 10, 2020 /PRNewswire/ -- Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug - CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial of CS02... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020

Welcome to NETX - Global Conglomerate Bellagraph Nova Group Launches Latest Technolgy Platform Focusing on AI + Robotics + Healthcare

PARIS, July 10, 2020 /PRNewswire/ -- Headquartered in Paris, France, the Bellagraph Nova Group (BN Group), the multi-national conglomerate overseeing 31 business entities across 100 countries is the world's fastest growing 360 degree lifestyle platform.

Read more ››
By: PR Newswire Association LLC. - 10 Jul 2020

AGENT Study Update With Regards to COVID-19

GOTHENBURG, Sweden, July 10, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL), informs that the outbreak of COVID-19 has affected the general situation of the AGENT study activities. Patient recruitment has been ongoing without interruption during... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
Related companies:  Isofol Medical AB

World's First FDA IDE Coronary Patient Treated With a DEB

NYON, Switzerland, July 10, 2020 /CNW/ -- MedAlliance has announced enrollment of the first patient in its study of SELUTION SLR(TM) 014 DEB for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA... Read more ››

By: PR Newswire Association LLC. - 10 Jul 2020
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »

Explore our database of over 50,000 companies